Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?
- 1 November 2005
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 15 (6) , 1014-1022
- https://doi.org/10.1111/j.1525-1438.2005.00185.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancerAnnals of Oncology, 2003
- Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective studyGynecologic Oncology, 2003
- Expression of Apoptosis-Related Proteins Is an Independent Determinant of Patient Prognosis in Advanced Ovarian CancerJournal of Clinical Oncology, 2000
- Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patientsBJOG: An International Journal of Obstetrics and Gynaecology, 1999
- Clinical Significance of Apoptosis-Related Factors p53, Mdm2, and Bcl-2 in Advanced Ovarian CancerJournal of Clinical Oncology, 1999
- Oncogene Expression: Long-Term Compared With Short-Term Survival in Patients With Advanced Epithelial Ovarian CancerObstetrics & Gynecology, 1998
- Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1New England Journal of Medicine, 1996
- p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial overian carcinomaCancer, 1995
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983
- Ploidy as a Prognostic Factor in Ovarian CancerInternational Journal of Gynecological Pathology, 1983